LEIDOS BIOMEDICAL RESEARCH INC: $826M Department of Health and Human Services Contract
Summary
Leidos Holdings ($LDOS) received a $826M task order from NIH for NCI operational support, adding significant revenue to its healthcare services backlog.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.Leidos secured a $826M NIH task order for NCI operational support.
- 2.The award adds ~$413M annually to Leidos' backlog, supporting its healthcare revenue.
- 3.Leidos continues to strengthen its position in government health IT and research support.
Market Implications
Leidos' stock may see positive sentiment from this award, as it demonstrates continued demand for its services in the healthcare sector. Investors should view this as a sign of stable revenue growth from government contracts.
Full Analysis
Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, was awarded a $826M delivery order by the National Institutes of Health for the NCI Operational Task Order covering FY26-FY27. This contract involves providing operational and technical support to the National Cancer Institute. Leidos Holdings ($LDOS) is the publicly traded parent company, and this award represents approximately $413M in annual revenue, or about 2.7% of its FY2025 revenue of $15.3B. While no direct legislative connection was identified among the provided bill signals, the award reflects continued government investment in healthcare research infrastructure. Subcontractors for this contract may include IT services and scientific equipment providers, but specific names are not disclosed. Historically, Leidos has consistently won large task orders from NIH, contributing to steady growth in its health and civil segment. This award reinforces Leidos' position as a key contractor for biomedical research support.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
What the bill does
Direct award of delivery order for NCI operational support
Who must act
National Institutes of Health (NIH) awarded to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings
What happens
$826M added to Leidos' backlog over two years, representing approximately $413M in annual revenue, or about 2.7% of FY2025 revenue
Stock impact
Leidos will provide operational and technical support to the National Cancer Institute, strengthening its health and civil segment. This award adds to Leidos' growing healthcare portfolio and supports its revenue base.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Department of Homeland Security Appropriations Act, 2027
LEIDOS BIOMEDICAL RESEARCH INC: $484M Department of Health and Human Services Contract
LEIDOS, INC.: $458M Department of Homeland Security Contract
LEIDOS BIOMEDICAL RESEARCH INC: $342M Department of Health and Human Services Contract
LEIDOS BIOMEDICAL RESEARCH INC: $484M Department of Health and Human Services Contract
QTC MEDICAL SERVICES INC: $336M Department of Veterans Affairs Contract
LEIDOS, INC.: $422M Department of Homeland Security Contract
Slash the Pentagon Act
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Streamlining Access to Government Services Through America.gov
The executive order directs the General Services Administration to create America.gov, a unified digital portal for federal services, integrating Login.gov for authentication and requiring agencies to expose their digital services via APIs. It also mandates the use of AI (referred to as 'super intelligence') with transparency safeguards, while preserving existing service channels and excluding tax and defense/intelligence services.
Enhancing Program Integrity and Integrity and Interagency Coordination in the Administration of the H-1B Nonimmigrant Visa Program
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
Restriction on Entry of Certain Nonimmigrant Workers
This proclamation extends for an additional 12 months the existing restriction on entry of H-1B nonimmigrant workers, which requires a $100,000 payment per petition (with limited exceptions) and is supported by a DHS weighted selection process that prioritizes higher-skilled, higher-paid workers. The action continues to target IT staffing and outsourcing firms that have abused the program, and it maintains the requirement for ongoing rulemakings by DHS and DOL to further reform wage protections and program integrity.
Contract Details
Recipient
LEIDOS BIOMEDICAL RESEARCH INC
Award Amount
$825,985,691
Awarding Agency
Department of Health and Human Services
Sub-Agency
National Institutes of Health
Contract Type
DELIVERY ORDER
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →